|
Market Closed -
Nasdaq
16:00:00 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 2.955 USD | -4.37% |
|
-3.75% | -13.34% |
| 08-06 | B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating | MT |
| 08-05 | LifeMD, Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 8.125 | +174.96% | 8 | ||||||
| 297.3 | +13.99% | 27 | ||||||
| 202.47 | +21.6% | 15 | ||||||
| 340 | +19.38% | 3 | ||||||
| 44.78 | -4.05% | 9 | ||||||
| 27 | +73.97% | 5 | ||||||
| 57.86 | +71.99% | 7 | ||||||
| - | 92.03 | +56.19% | 2 | |||||
| - | - | 7.632 | +6.38% | 1 | ||||
| 6.025 | +73.63% | 2 | ||||||
| - | 6.5 | +39.78% | 2 | |||||
| 9.75 | +26.95% | 4 | ||||||
| 0.9125 | +42.58% | 4 | ||||||
| - | 297.5 | +70.1% | 2 | |||||
| - | 7.694 | +147.62% | 2 | |||||
| - | - | 9,000 | +4.29% | 1 | ||||
| 5.769 | +39.02% | 13 | ||||||
| - | 17.25 | -6.35% | 2 | |||||
| Average | 579.37 | +48.45% | 6 | ||||||
| Weighted average by Cap. | 292.16 | +20.69% | 19 |
- Stock Market
- Stocks
- LFMD Stock
- Sector LifeMD, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
